Home Insemination Protocol: Reference Materials

This package supplements the MAPASGEN video instructions and home insemination protocol, focusing on three key aspects: reference parameters and instruments, reproductive genetics (donor screening), and scientifically grounded calculation of the fertile window.

Watch: Home Insemination Video Guide PDF Guide

Section 1. Home Insemination Protocol — Reference Materials

1.1. Safe Instrumentation (Cell-Compatible Materials)

Standard medical syringes and household plastic containers contain phthalates, cytotoxic lubricants, and rubber that reduce sperm motility by 20–40%. Selecting materials compatible with cells is critical.

Type of Instrument	Recommended Characteristics	Critical Prohibition
Applicator syringes	Specialized insemination applicators without needle, solid polypropylene (PP), no silicone-based lubricant.	Syringes with black rubber plunger (contain phthalates and oils).
Collection containers	Sterile inert medical plastic (PP, PETG), BPA- and phthalate-free. ISO 9001 certified.	Non-sterile household containers, spermicide-coated condoms.
Cervical cap	Medical Grade A silicone cervical caps (without pigments and additives).	Menstrual cups with uncertified dyes and phthalate additives.
Lubricants	Fertility lubricants with neutral pH 7.2–7.8. Verify sperm compatibility on the package.	Regular lubricants (water-based, oil-based, silicone-based)—damage cell membranes.

1.2. Critical Environmental Parameters

⏱ The 20-minute rule: no more than 20 minutes should pass from collection to insemination, at 36–37°C. Every 5 minutes of delay at room temperature reduces motility by ~10%.

Parameter	Standard Value	Biological Basis
Temperature	36.5°C – 37.0°C	Cooling below 20°C causes thermal shock. Heating above 38°C causes protein denaturation and cell death.
Time Window	Up to 20 minutes from collection	After 20 minutes enzymatic activity drops. Procedure must be completed within this interval.
Light and Oxygen	Minimal direct UV exposure	Direct sunlight and prolonged oxygen contact increase oxidative DNA stress in cells.

1.3. Optimal Positioning Scheme

Primary position: Supine with elevated pelvis (pillow under sacrum at 20–30° angle). Duration: 20–30 minutes without movement. Avoid: abdominal muscle tension and sudden movements immediately after the procedure.

Section 2. Genetic Shield: Donor Screening

2.1. Mandatory Genetic Screening (Carrier Screening)

Hidden carrier status for autosomal recessive diseases does not manifest in the donor himself. However, if the biological mother is also a carrier of the same mutation, there is a 25% risk of the child being born with severe pathology. Use the interactive Mendelian calculator at mapasgen.com/genetics.

Gene / Protein	Disease	Why Screening Is Essential
CFTR	Cystic Fibrosis	One of the most common severe hereditary diseases. Found in 1 of 25–30 Europeans.
SMN1	Spinal Muscular Atrophy (SMA)	Progressive neurological disease with muscle atrophy. Screening determines SMN1 gene copy number.
PAH / GALT	Phenylketonuria / Galactosemia	Metabolic disorders requiring lifelong strict dietary control from birth.
Panel 100+	Extended Screening (NGS)	Allows comparison of maternal and donor genetic profiles to exclude overlap in recessive alleles.

2.2. Interpreting Results: What to Do When Carrier Status Is Found

Recessive carrier (1 mutation, 1 normal): risk is low. Screen the mother for the same gene. If the mother is normal, risk is near zero.
Homozygous or data unavailable: genetic counseling advised. May need to select a different donor.
Incompatible profiles (both carriers of same recessive disease): 25% risk. PGD with IVF or different donor recommended.

2.3. Karyotyping and Infectious Status

Donor karyotype (chromosomal analysis) excludes balanced translocations. Infectious profile: HIV 1/2, Hepatitis B and C, Syphilis (RPR), Chlamydia, Mycoplasma. Testing should be conducted no more than 3–6 months before use.

Section 3. Fertile Window: Calculations and Biomarkers

Marker	How It Is Measured	Interpretation
Luteinizing Hormone (LH)	Urine dipstick or stream tests; digital trackers (more reliable)	LH surge = ovulation within 24–36 hours. Ideal time for first insemination.
Cervical Mucus	Visual and physical examination (consistency, stretchiness)	During fertile window: clear, elastic, stretchy (like raw egg white). Protects cells from acidity.
Basal Body Temperature (BBT)	Daily measurement with special thermometer immediately upon waking	Rise of 0.3–0.5°C indicates ovulation. Confirms retroactively; cannot predict.

3.2. Practical Example of Fertile Window Calculation

Day 12: Start LH surge tests (morning and evening). Check cervical mucus. Day 13: Peak LH (two lines) — ovulation within 24–36 h. First insemination in the evening; complete within 20 min of collection. Day 14: Second insemination in the morning (12–24 h after first). Days 15–21: Track basal body temperature.

3.3. Key Principles for Choosing Trackers

When possible, use digital trackers with sensor technology (e.g., Clearblue Fertility Monitor) rather than strip tests for more reliable fertile window predictions.

Full step-by-step protocol — in the The Biology Code: How-To section on MAPASGEN Hub. PDF guide available for Pro & Premium subscribers.

Summary: From Knowledge to Responsibility

Technical control: use cell-compatible instruments, adhere to temperature regime and the 20-minute rule.
Genetic responsibility: complete donor screening (carrier screening, karyotype, infectious status). Eliminates 95% of detectable genetic risks.
Biological timing: precise calculation of the fertile window based on LH tests, cervical mucus, and basal body temperature.

Always consult a reproductive endocrinologist for individual assessment and planning.